Publication

Chronic social defeat causes dysregulation of systemic glucose metabolism via the cerebellar fastigial nucleus

February 19, 2025
ActivityScan Assay
Disease Modeling
MaxOne
MaxOne Chip
Pharmacology & Toxicology
Spike Sorting
Brain Slices
Taiga Ishimoto, Takashi Abe, Yuko Nakamura, Tomonori Tsuyama, Kunio Kondoh, Naoto Kajitani, Kaede Yoshida, Yuichi Takeuchi, Kan X. Kato, Shucheng Xu, Maru Koduki, Momoka Ichimura, Takito Itoi, Kenta Shimba, Yoshifumi Yamaguchi, Masabumi Minami, Shinsuke Koike, Kiyoto Kasai, Jessica J. Ye, Minoru Takebayashi, Kazuya Yamagata, Chitoku Toda
Download Resource
Access Resource
Back

Abstract

Details

Chronic psychological stress leads to hyperglycemia through the endocrine and sympathetic nervous systems, which contributes to the development of type II diabetes mellitus (T2DM). Higher plasma corticosteroids after stress is one well-established driver of insulin resistance in peripheral tissues. However, previous studies have indicated that only a fraction of patients with depression and post-traumatic disorder (PTSD) who develop T2DM exhibit hypocortisolism, so corticosteroids do not fully explain psychological stress-induced T2DM. Here, we find that chronic social defeat stress (CSDS) in mice enhances gluconeogenesis, which is accompanied by a decrease in plasma insulin, an increase in plasma catecholamines, and a drop in plasma corticosterone levels. We further reveal that these metabolic and endocrinological changes are mediated by the activation of neurons projecting from the cerebellar fastigial nucleus (FN) to the medullary parasolitary nucleus (PSol). These neurons are crucial in shifting the body’s primary energy source from glucose to lipids. Additionally, data from patients with depression reveal correlations between the presence of cerebellar abnormalities and both worsening depressive symptoms and elevated HbA1c levels. These findings highlight a previously unappreciated role of the cerebellum in metabolic regulation and its importance as a potential therapeutic target in depression, PTSD, and similar psychological disorders.